Exscientia Archives - AI Insider

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Insider Brief Recursion and Exscientia announced their business combination has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion. Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs,

20 Nov 2024 · 4 min read

Exscientia

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Trending today

Kevel Announces $52M in Funding to Scale AI-Driven Infrastructure for the Future of Commerce Media

U.S. Orders Federal Agencies to Remove DeepSeek AI Products Over National Security Concerns

Mach9 Secures $34M Series A to Bring Civil Engineering into the AI Era

Reliable Robotics Raises Another $115M, Pushing Series D to $275M in Funding

Nvidia Expands Physical AI Stack Across Robotics, Humanoids and Factory Automation

Exscientia

AI Drug Discovery Space Leaders Recursion And Exscientia Officially Combine

Trending today

Kevel Announces $52M in Funding to Scale AI-Driven Infrastructure for the Future of Commerce Media

U.S. Orders Federal Agencies to Remove DeepSeek AI Products Over National Security Concerns

Mach9 Secures $34M Series A to Bring Civil Engineering into the AI Era

Reliable Robotics Raises Another $115M, Pushing Series D to $275M in Funding

Nvidia Expands Physical AI Stack Across Robotics, Humanoids and Factory Automation

The AI economy, every weekday morning